University of Texas MD Anderson Cancer Center

LIXTE Biotechnology commences Phase 1b/2 clinical trial in ovarian cancer

Pallavi Madhiraju - January 29, 2024 0

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has initiated a pivotal Phase 1b/2 clinical trial, in partnership with GSK, to evaluate the potential of ... Read More

LIXTE Biotechnology commences Phase 1b/2 clinical trial in ovarian cancer

SmartStop Self Storage expands into Washington, D.C., and San Jose with premium facilities

Third Point to acquire AS Birch Grove to boost credit capabilities

Rocket Lab wraps up 2024 with Synspective satellite launch, achieves 60% growth in missions

Fleeing driver crashes truck into Texas mall, injuring five before fatal shooting

US Navy jet downed in Red Sea friendly fire incident

Tragic helicopter crash: Turkish hospital struck, all onboard killed

Rumble secures $775m investment from Tether to fuel decentralized growth

Novo Nordisk’s CagriSema demonstrates superior weight loss results in REDEFINE 1 trial

Volkswagen guarantees no layoffs for a decade in historic worker deal

Cosmo First introduces advanced paint protection films to redefine car care

Suraksha Diagnostic reports strong growth in Q2 and H1 FY25 financial results

Saksoft strengthens digital transformation portfolio with ZeTechno acquisition

Tragedy in Mohali: One dead in building collapse, rescue teams race against time

Seven Indian nationals injured in Germany’s Magdeburg attack: Government ensures assistance

Robin Uthappa issues clarification amid provident fund fraud case

US retaliates with precision strikes on Houthi targets after Tel Aviv missile attack

Horrific bus-truck collision in Minas Gerais sparks road safety debate

Ukrainian drones penetrate 600 miles into Russia – what it means for the war

Robin Uthappa faces arrest for alleged provident fund fraud: A legal storm brews

Sanction against Arvind Kejriwal: AAP demands transparency amid liquor scam allegations